Adaptive Optimization Boosted the Production of Moenomycin A in the Microbial Chassis Streptomyces albus J1074-Reference-Cited by-同舟云学术

Adaptive Optimization Boosted the Production of Moenomycin A in the Microbial Chassis Streptomyces albus J1074

Published:2021-09-02 Issue:9 Volume:10 Page:2210-2221
ISSN:2161-5063
Container-title:ACS Synthetic Biology
language:en
Short-container-title:ACS Synth. Biol.

Author:

Li Xing¹,Hu Xiaojing¹,Sheng Yong¹,Wang Hengyu¹,Tao Meifeng¹^ORCID,Ou Yixin¹,Deng Zixin¹,Bai Linquan¹,Kang Qianjin¹^ORCID

Affiliation:

1. State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, and School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China

Funder

Ministry of Science and Technology of the People's Republic of China

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Shanghai Jiao Tong University Medical-Engineering Cross Fund

Publisher

American Chemical Society (ACS)

Subject

Biochemistry, Genetics and Molecular Biology (miscellaneous),Biomedical Engineering,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acssynbio.1c00094

Reference50 articles.

1. Streptomyces species: Ideal chassis for natural product discovery and overproduction

2. Synthetic Biology Tools for Novel Secondary Metabolite Discovery in Streptomyces

3. Recent advances in heterologous expression of natural product biosynthetic gene clusters in Streptomyces hosts

4. Heterologous expression of bacterial natural product biosynthetic pathways

5. Reconstitution of Kinamycin Biosynthesis within the Heterologous Host Streptomyces albus J1074

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in genome mining and synthetic biology for discovery and biosynthesis of natural products;Critical Reviews in Biotechnology;2024-08-12

2. Rational Engineering of Secondary Metabolic Pathways in a Heterologous Host to Enable the Biosynthesis of Hibarimicin Derivatives with Enhanced Anti-Melanomic Activity;Engineering;2024-07

3. Structural diversity, bioactivity, and biosynthesis of phosphoglycolipid family antibiotics: Recent advances;BBA Advances;2022